Hidekazu Kawanaka

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

W. Shimizu, Y. Miyauchi, I. Tsuboi, 2020, Cardiovascular Diabetology.

Mid-term feasibility and safety of downgrade procedure from defibrillator to pacemaker with cardiac resynchronization therapy

W. Shimizu, I. Tsuboi, Y. Iwasaki, 2018, International journal of cardiology. Heart & vasculature.

Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial

W. Shimizu, Y. Miyauchi, I. Tsuboi, 2020, Cardiovascular Diabetology.

Usefulness of rosuvastatin to prevent periprocedural myocardial injury in patients undergoing elective coronary intervention.

K. Asai, T. Ohba, M. Yasutake, 2013, The American journal of cardiology.

Therapeutic angiogenesis by controlled-release fibroblast growth factor in a patient with Churg-Strauss syndrome complicated by an intractable ischemic leg ulcer.

Y. Tabata, S. Tara, M. Yasutake, 2009, The American journal of the medical sciences.

In-stent restenosis caused by calcified nodule 11 years after paclitaxel eluting stent implantation treated with drug-coated balloon following rotational atherectomy

W. Shimizu, J. Tanabe, Masahiro Tajiri, 2019, Cardiovascular Intervention and Therapeutics.

A Fever in Acute Aortic Dissection is Caused by Endogenous Mediators that Influence the Extrinsic Coagulation Pathway and Do Not Elevate Procalcitonin.

W. Shimizu, Keiji Tanaka, H. Murata, 2016, Internal medicine.

Takotsubo Cardiomyopathy Presenting with QT Prolongation and Torsade de Pointes in a Patient with Coronavirus Disease 2019

M. Ogano, Hidekazu Kawanaka, Keita Hibako, 2022 .